/Moderna%20Inc%20HQ-by%20hapabapa%20via%20iStock.jpg)
Hedge funds are betting hard against Moderna (MRNA). But the company's pipeline tells a very different story, and contrarian investors are paying close attention.
According to Bank of America's equity team, MRNA stock has the highest short interest of any S&P 500 ($SPX) stock, with 17.8% of its float sold short by hedge funds. That's a massive vote of no confidence from Wall Street's biggest players.